Predicting malignant intraductal papillary mucinous neoplasm: A single-center review

American Journal of Surgery

Volumn 201, Issue 5, 2011, Pages 575-579

  Cone, Molly M ^a   Rea, Jennifer D ^a   Diggs, Brian S ^a   Douthit, Miriam A ^a   Billingsley, Kevin G ^a   Sheppard, Brett C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cancer; Intraductal papillary mucinous neoplasm; Pancreas

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA; CONTROLLED STUDY; DYSPLASIA; FEMALE; HOSPITAL READMISSION; HUMAN; INTERNATIONAL CONSENSUS GUIDELINE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; MAYO CLINIC; PANCREAS FISTULA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 79955688814     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2011.01.003     Document Type: Article

References (27)

1. Ohashi K, Murakami Y, Murayama M, et al. Four cases of mucin-producing cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc 1982;20:348-51.
2. Kloppel G, Solcia E, Longnecker D, et al. World Health Organization International Histological Classification of Tumours: Histologicaly Typing Tumours of the Exocrine Pancreas. 2nd edn. Berlin: Springer; 1996:1-61.
3. Tanaka M, Chari S, Adsay V, et al. International association of P. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.
4. Lee CJ, Scheiman J, Anderson MA, et al. Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: Is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg 2008;12:234-42.
5. Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 2007;102:1759-64. (Pubitemid 47206677)
6. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 2007;246:644-51. (Pubitemid 47480616)
7. Hirono S, Tani M, Kawai M, et al. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Arch Surg 2009;144:345-9.
8. Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239:678-85.
9. Weitz J, Buchler MW. Branch intraductal papillary mucinous neoplasms: just the tip of the iceberg? Gut 2008;57:1490-1.
10. Nagai K, Doi R, Kida A, et al. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg 2008;32:271-8.
11. Walsh RM, Vogt DP, Henderson JM, et al. Natural history of indeterminate pancreatic cysts. Surgery 2005;138:665-70.
12. Allen PJ, D'Angelica M, Gonen M, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg 2006;244:572-82.
13. Bassi C, Crippa S, Salvia R. Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife?[comment]. Gut 2008;57:287-9.
14. Ohno E, Hirooka Y, Itoh A, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg 2009;249:628-34.
15. Allen PJ, Jaques DP. D'angelica, et al. Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg 2003;7:970-7. (Pubitemid 37524064)
16. Salvia R, Crippa S, Falconi M, et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 2007;56:1086-90.
17. Goh BKP. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma. Surgery 2007;141:545-6. (Pubitemid 46441316)
18. Maire F, Couvelard A, Hammel P, et al. Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc 2003;58:701-6. (Pubitemid 37370483)
19. Bassi C, Sarr MG, Lillemoe KD, et al. Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg 2008;12:645-50.
20. Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000;24:1372-7.
21. Parikh P, Shiloach M, Cohen M, et al. Pancreatectomy risk calculator: an ACS-NSQIP resource. Oxford: HPB; 2010:488-97.
22. McArdle CS, McMillan DC, Hole DJ. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 2003;90:711-5. (Pubitemid 36760600)
23. Teh SH, Diggs BS, Deveney CW, et al. Patient and hospital characteristics on the variance of perioperative outcomes for pancreatic resection in the united states: a plea for outcome-based and not volume- based referral guidelines. Arch Surg 2009;144:713-21.
24. Vin Y, Sima CS, Getrajdman GI, et al. Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg 2008;207:490-8.
25. Klarenbeek BR, van der Peet DL, Cuesta MA. Laparoscopic sigmoid resection for diverticulitis decreases major morbidity rates: a randomized controlled trial. Ann Surg 2009;250:501-2.
26. Sarli L, Pietra N, Sansebastiano G, et al. Reduced postoperative morbidity after elective laparoscopic cholecystectomy: atratified matched case-control study. World J Surg 1997;21:872-8.
27. Holavanahalli RK, Lezotte DC, Hayes MP, et al. Profile of patients lost to follow-up in the burn injury rehabilitation model systems' longitudinal database. J Burn Care Res 2006;27:703-12. (Pubitemid 44450644)